These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9971830)

  • 1. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.
    Mariani R; Wong S; Mulder LC; Wilkinson DA; Reinhart AL; LaRosa G; Nibbs R; O'Brien TR; Michael NL; Connor RI; Macdonald M; Busch M; Koup RA; Landau NR
    J Virol; 1999 Mar; 73(3):2450-9. PubMed ID: 9971830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
    Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium.
    Struyf F; Thoelen I; Charlier N; Keyaerts E; Van der Donck I; Wuu J; Van Ranst M
    Hum Hered; 2000; 50(5):304-7. PubMed ID: 10878474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.
    Lee B; Doranz BJ; Rana S; Yi Y; Mellado M; Frade JM; Martinez-A C; O'Brien SJ; Dean M; Collman RG; Doms RW
    J Virol; 1998 Sep; 72(9):7450-8. PubMed ID: 9696841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of CCR5-Delta32, CCR5 promoter 59029 A/G, CCR2-64I and SDF1-3'A genetic polymorphisms in HIV-1 infected and uninfected patients in the west region of Cameroon.
    Nkenfou CN; Mekue LC; Nana CT; Kuiate JR
    BMC Res Notes; 2013 Jul; 6():288. PubMed ID: 23880174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
    van Rij RP; de Roda Husman AM; Brouwer M; Goudsmit J; Coutinho RA; Schuitemaker H
    J Infect Dis; 1998 Dec; 178(6):1806-11. PubMed ID: 9815240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
    Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
    Kostrikis LG; Neumann AU; Thomson B; Korber BT; McHardy P; Karanicolas R; Deutsch L; Huang Y; Lew JF; McIntosh K; Pollack H; Borkowsky W; Spiegel HM; Palumbo P; Oleske J; Bardeguez A; Luzuriaga K; Sullivan J; Wolinsky SM; Koup RA; Ho DD; Moore JP
    J Virol; 1999 Dec; 73(12):10264-71. PubMed ID: 10559343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4.
    Shieh B; Liau YE; Hsieh PS; Yan YP; Wang ST; Li C
    Int Immunol; 2000 Sep; 12(9):1311-8. PubMed ID: 10967026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CCR2-V64I polymorphism affects stability of CCR2A isoform.
    Nakayama EE; Tanaka Y; Nagai Y; Iwamoto A; Shioda T
    AIDS; 2004 Mar; 18(5):729-38. PubMed ID: 15075507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
    Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype.
    Martinson JJ; Hong L; Karanicolas R; Moore JP; Kostrikis LG
    AIDS; 2000 Mar; 14(5):483-9. PubMed ID: 10780710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
    Hendel H; Hénon N; Lebuanec H; Lachgar A; Poncelet H; Caillat-Zucman S; Winkler CA; Smith MW; Kenefic L; O'Brien S; Lu W; Andrieu JM; Zagury D; Schächter F; Rappaport J; Zagury JF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):381-6. PubMed ID: 9833747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
    Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson P; Kaldor JM; Stewart GJ
    AIDS; 2000 Jan; 14(2):103-8. PubMed ID: 10708279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the CCR2-64I/CCR5-59653T haplotype linkage disequilibrium in a sample of Polish population.
    Lewandowska M; Trzeciak WH; Jagodzinski PP
    Genetika; 2003 Jun; 39(6):831-3. PubMed ID: 12884524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms.
    Rigato PO; Hong MA; Casseb J; Ueda M; de Castro I; Benard G; Duarte AJ
    Curr HIV Res; 2008 Sep; 6(5):466-73. PubMed ID: 18855658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.
    Mangano A; Kopka J; Batalla M; Bologna R; Sen L
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):52-7. PubMed ID: 10708056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.